The metabolism and secretion of aldosterone in elderly subjects

The Journal of Clinical Investigation
C FloodS Willoughby

Abstract

The secretion rates [34 +/- 6 (SE) mug per day, 9 subjects] and metabolic clearance rates (MCR) [1,288 +/- 120 (SE) L of plasma per day, 9 subjects] of aldosterone in elderly subjects are significantly lower than those of young subjects [77 +/- 7 (SE) mug per day and 1,631 +/- 106 (SE) L per day, respectively]. There is a correlation of the MCR and secretion rate values (p = 0.02), but the calculated plasma concentrations (secretion rate/MCR) are also significantly low in the elderly subjects [2.6 +/- 0.3 (SE) compared with concentrations in the plasma from young subjects of 4.7 +/- 0.6 (SE) mug per 100 ml plasma]. The urinary excretion of radioactivity from oral and intravenously administered labeled aldosterone as aldosterone in the neutral extract, as aldosterone released by acid hydrolysis, and as tetrahydroaldosterone released by incubation with beta-glucuronidase is generally similar for young and elderly subjects except that a larger portion of the oral compared with the intravenous dose is excreted as free aldosterone in the elderly subjects, indicating that the splanchnic extraction is reduced. The calculated splanchnic blood flow (assuming no alteration in extrasplanchnic metabolism) is also slightly lowered. Therefor...Continue Reading

References

Mar 1, 1963·The Journal of Clinical Endocrinology and Metabolism·L P ROMANOFFG PINCUS
Nov 1, 1964·The Journal of Clinical Endocrinology and Metabolism·R H UNDERWOOD, J F TAIT
Feb 1, 1965·The Journal of Clinical Endocrinology and Metabolism·J F TAITJ BOUGAS
Mar 1, 1965·The Journal of Clinical Investigation·C A CAMARGOJ A LUETSCHER

❮ Previous
Next ❯

Citations

Feb 1, 1991·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R EastellB L Riggs
Oct 14, 1977·European Journal of Clinical Pharmacology·R L NationB Learoyd
Jul 1, 1987·Neuroscience and Behavioral Physiology·V V Frol'kisL V Magdich
Sep 1, 2005·International Urology and Nephrology·Fred G Silva
Mar 15, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·P LijnenP Corvol
Jul 1, 1994·Neurobiology of Aging·A Svanborg
Jan 1, 1986·Experimental Gerontology·R D Lindeman, R Goldman
Feb 9, 2000·Pharmacology & Therapeutics·M K Agarwal, M Mirshahi
Feb 12, 1981·The New England Journal of Medicine·D C BatlleN A Kurtzman
Nov 1, 1969·The Journal of Clinical Investigation·J F Tait, B Little
Feb 25, 2014·La Presse médicale·Morgane CommereucChristophe Ridel
May 1, 1978·Scandinavian Journal of Clinical and Laboratory Investigation·K Tolagen, B E Karlberg
Nov 1, 1975·Kidney International·P WeidmannJ de Lima
May 3, 2011·Néphrologie & thérapeutique·Alexandre LautretteBertrand Souweine
Sep 22, 2009·Clinics in Geriatric Medicine·Khaled Abdel-Kader, Paul M Palevsky
Apr 1, 1974·Metabolism: Clinical and Experimental·M G Crane, J J Harris
Apr 1, 1972·The American Journal of Medicine·M G CraneV J Johns
May 1, 1973·The American Journal of Cardiology·H P DustanR C Tarazi
Mar 1, 1974·Metabolism: Clinical and Experimental·A H Vagnucci, A P Shapiro
Sep 17, 2002·The American Journal of Cardiology·Chamberlain I ObialoTariq Mirza
Aug 1, 1989·Journal of the American Geriatrics Society·B R Meyer
Aug 1, 1980·Journal of the American Geriatrics Society·S MorimotoT Kigoshi
Jan 1, 1984·Journal of the American Geriatrics Society·A Frocht, H Fillit
Jul 1, 1981·Journal of the American Geriatrics Society·S MorimotoR Takeda
Jul 1, 1984·Clinics in Endocrinology and Metabolism·M Lye
Mar 1, 1983·The American Journal of Medicine·R HegstadM Wisgerhof
Jan 1, 1978·Clinical Endocrinology·L N ParkerW D Odell
Oct 1, 1984·Biochemical Medicine·P CuginiG Cornelissen
Jun 1, 1972·Circulation Research·E H BlaineP D Harris
Sep 18, 1999·Hypertension·D G Warnock
Jan 1, 1982·Journal of the American College of Nutrition·R D Lindeman
May 1, 1980·Journal of the American Geriatrics Society·T SarutaE Kato
Feb 23, 2019·Frontiers in Endocrinology·Andreas YiallourisElizabeth O Johnson
Jan 28, 2014·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Keren Doenyas-BarakShlomo Vinker
Feb 1, 1983·Journal of Endocrinological Investigation·P CuginiT Kawasaky
Jun 1, 1979·The American Journal of Physiology·L N Parker, W D Odell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.